Dr. Dalbagni – who cares for patients with bladder cancer, kidney cancer, penile cancer, and sarcomas – explains treatments offered at Memorial Sloan-Kettering, which can help patients maintain their quality of life.
To treat his soft tissue sarcoma, 50-year-old Ron Kraemer chose Memorial Sloan-Kettering for care and support that could keep him playing music and working as a personal fitness trainer.
With the genomics revolution, scientists and physicians have increasingly been able to peer at the inner workings of tumor cells and pinpoint the specific genetic changes that transform them from their cells of origin into cancer.
In 2003, Mary McCabe was recruited to lead Memorial Sloan-Kettering Cancer Center’s Cancer Survivorship Initiative and since that time has worked to develop a comprehensive program for cancer survivors, which includes follow-up care, research, and education and training.
